Nullifying drug-induced sensitization: Behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats

Drug and Alcohol Dependence

Volumn 86, Issue 1, 2007, Pages 55-66

  McDaid, J ^a   Tedford, C E ^b   Mackie, A R ^a   Dallimore, J E ^a   Mickiewicz, A L ^a   Shen, F ^a   Angle, J M ^b   Napier, T C ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Solentix BioSciences Inc   (United States)

Author keywords

2 Adrenergic receptors; 5 HT2 receptors; D1 dopamine receptors; Methamphetamine; Mirtazapine; Ventral pallidum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; METHAMPHETAMINE; MIRTAZAPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BINDING AFFINITY; DRUG DEPENDENCE; DRUG SENSITIZATION; ELECTROPHYSIOLOGY; EVALUATION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ACTION POTENTIALS; ADRENERGIC AGENTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DOPAMINE; ELECTROCHEMISTRY; GLOBUS PALLIDUS; KETANSERIN; LOCOMOTION; MALE; METHAMPHETAMINE; MIANSERIN; MICROELECTRODES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE D1; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 33750714820     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.05.014     Document Type: Article

References (79)

1. Baumann M.H., and Rothman R.B. Alterations in sertonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Soc. Biol. Psychiatry 44 (1998) 578-591
2. Bengtson C.P., Lee D.J., and Osborne P.B. Opposing electrophysiological actions of 5-HT on noncholinergic and cholinergic neurons in the rat ventral pallidum in vitro. J. Neurophysiol. 92 (2004) 433-443
3. Besson M.J., Graybiel A.M., and Nastuk M.A. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26 (1988) 101-119
4. Bonhomme N., Cador M., Stinus L., Le Moal M., and Spampinato U. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res. 675 (1995) 215-223
5. Bourdelais A., and Kalivas P.W. Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res. 516 (1990) 132-136
6. Brady A.M., Glick S.D., and O'Donnell P. Selective disruption of nucleus accumbens gating mechanisms in rats behaviorally sensitized to methamphetamine. J. Neurosci. 25 (2005) 6687-6695
7. Callahan P.M., and Cunningham K.A. Modulation of the discriminative stimulus properties of cocaine by 5- HT1B and 5-HT2C receptors. J. Pharmacol. Exp. Ther. 274 (1995) 1414-1424
8. Crawford C.A., and Levine M.S. Dopaminergic function in the neostriatum and nucleus accumbens of young and aged Fischer 344 rats. Neurobiol. Aging 18 (1997) 57-66
9. Crawford C.A., Choi F.Y., Kohutek J.L., Yoshida S.T., and McDougall S.A. Changes in PKA activity and Gs alpha and Golf alpha levels after amphetamine- and cocaine-induced behavioral sensitization. Synapse 51 (2004) 241-248
10. Cremers T.I., Giorgetti M., Bosker F.J., Hogg S., Arnt J., Mork A., Honig G., Bogeso K.P., Westerink B.H., den Boer H., Wikstrom H.V., and Tecott L.H. Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 29 (2004) 1782-1789
11. Dave K.D., Quinn J.L., Harvey J.A., and Aloyo V.J. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit. Pharmacol. Biochem. Behav. 77 (2004) 623-629
12. Davidson C., Lazarus C., Xiong X., Lee T.H., and Ellinwood E.H. 5-HT(2) receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur. J. Pharmacol. 453 (2002) 255-263
13. de Boer T.H., Maura G., Raiteri M., de Vos C.J., Wieringa J., and Pinder R.M. Neurochemical and autonomic pharmacological profiles of the 6-aza- analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 27 (1988) 399-408
14. de Boer T.H., Nefkens F., van Helvoirt A., and Van Delft A.M. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. J. Pharmacol. Exp. Ther. 277 (1996) 852-860
15. Dickinson S.L., and Curzon G. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology 22 (1983) 805-812
16. Groenewegen H.J., and Russchen F.T. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J. Comp. Neurol. 223 (1984) 347-367
17. Haddjeri N., Blier P., and De Montigny C. Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J. Affect. Disord. 51 (1998) 255-266
18. Hamamura T., Akiyama K., Akimoto K., Kashihara K., Okumura K., Ujike H., and Otsuki S. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546 (1991) 40-46
19. He C., Voigt R.M., Dallimore J.E., McDaid J., Chefer V.I., Shippenberg T.S., and Napier T.C. Cocaine-induced behavioral sensitization: correlation with attenuated dopamine release in the ventral pallidum. Soc. Neurosci. Abstr. 30 688.8 (2004)
20. Heidbreder C.A., Oertle T., and Feldon J. Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine. Neuroscience 89 (1999) 701-715
21. Heidenreich B.A., and Napier T.C. Effects of serotonergic 5-HT1A and 5-HT1B ligands on ventral pallidal neuronal activity. Neuroreport 11 (2000) 2849-2853
22. Heidenreich B.A., Mailman R.B., Nichols D.E., and Napier T.C. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine. J. Pharmacol. Exp. Ther. 273 (1995) 516-525
23. Henry D.J., and White F.J. Electrophysiological correlates of psychomotor stimulant-induced sensitization. Ann. N.Y. Acad. Sci. 654 (1992) 88-100
24. Henry D.J., and White F.J. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 15 (1995) 6287-6299
25. Hensler J.G., and Truett K.A. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity. Neuropsychopharmacology 19 (1998) 354-364
26. Hess E.J., Norman A.B., and Creese I. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. J. Neurosci. 8 (1988) 2361-2370
27. Hoyer D. Functional correlates of serotonin 5-HT1 recognition sites. J. Recept. Res. 8 (1988) 59-71
28. Hummel M., and Unterwald E.M. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. J. Cell Physiol. 191 (2002) 17-27
29. Istre E.D., Napier T.C., and Wolf W.A. Enhanced sensitivity to ventral pallidal serotonin receptors activation after withdrawal from repeated mehtamphetamine treatment. Soc. Neurosci. Abstr. 27 878.11 (2002) 27
30. Jones B.E., and Cuello A.C. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic - catecholamine, serotonin, and acetylcholine - neurons. Neuroscience 31 (1989) 37-61
31. Jones D.L., and Mogenson G.J. Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am. J. Physiol. 238 (1980) R65-R69
32. Kalivas P.W., and Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13 (1993) 266-275
33. Kelder J., Funke C., De Boer T., Delbressine L., Leysen D., and Nickolson V. A comparison of the physicochemical and biological properties of mirtazapine and mianserin. J. Pharm. Pharmacol. 49 (1997) 403-411
34. Kongsakon R., Papadopoulos K.I., and Saguansiritham R. Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. Int. Clin. Psychopharmacol. 20 (2005) 253-256
35. Kooyman A.R., Zwart R., Vanderheijden P.M., Van Hooft J.A., and Vijverberg H.P. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology 33 (1994) 501-507
36. Kuribara H., and Uchihashi Y. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J. Pharm. Pharmacol. 45 (1993) 1042-1045
37. Li Y., White F.J., and Wolf M.E. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology 151 (2000) 175-183
38. Ling W., and Shoptaw S. Integration of research in pharmacotherapy for addictive disease: where are we? Where are we going?. J. Addict. Dis. 16 (1997) 83-102
39. Maslowski R.J., and Napier T.C. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons. Eur. J. Pharmacol 200 (1991) 103-112
40. McDaid J., Dallimore J.E., Mackie A.R., Mickiewicz A.L., and Napier T.C. Cross-sensitization to morphine in cocaine-sensitized rats: behavioral assessments correlate with enhanced responding of ventral pallidal neurons to morphine and glutamate, with diminished effects of GABA. J. Pharmacol. Exp. Ther. 313 (2005) 1182-1193
41. McGrath C., Burrows G.D., and Norman T.R. Neurochemical effects of the enantiomers of mirtazapine in normal rats. Eur. J. Pharmacol. 356 (1998) 121-126
42. McMahon L.R., Filip M., and Cunningham K.A. Differential regulation of the mesoaccumbens circuit by serotonin 5- hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J. Neurosci. 21 (2001) 7781-7787
43. Mengual E., and Pickel V.M. Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse 43 (2002) 151-162
44. Meredith G.E., Switzer III R.C., and Napier T.C. Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum. Brain Res. 995 (2004) 14-22
45. Mitrovic I., and Napier T.C. Interactions between the mu opioid agonist DAMGO and substance P in regulation of the ventral pallidum. Synapse 23 (1996) 142-151
46. Munzar P., Laufert M.D., Kutkat S.W., Novakova J., and Goldberg S.R. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J. Pharmacol. Exp. Ther. 291 (1999) 239-250
47. Napier T.C., and Maslowski R.J. Electrophysiological verification for the presence of D1 and D2 dopamine receptors within the ventral pallidum. Synapse 17 (1994) 160-166
48. Napier T.C., and Potter P.E. Dopamine in the rat ventral pallidum/substantia innominata: biochemical and electrophysiological studies. Neuropharmacology 28 (1989) 757-760
49. Napier T.C., Muench M.B., Maslowski R.J., and Battaglia G. Is dopamine a neurotransmitter within the ventral pallidum/substantia innominata. Adv. Exp. Med. Biol. 295 (1991) 183-195
50. Parsons L.H., and Justice Jr. J.B. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61 (1993) 1611-1619
51. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York
52. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346 (1985) 205-230
53. Pazos A., Cortes R., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346 (1985) 231-249
54. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993) 247-291
55. Robinson T.E., Jurson P.A., Bennett J.A., and Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462 (1988) 211-222
56. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
57. Schama K.F., Howell L.L., and Byrd L.D. Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys. Psychopharmacology (Berl.) 132 (1997) 27-34
58. Self D.W., and Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18 (1995) 463-495
59. Semba K., Reiner P.B., McGeer E.G., and Fibiger H.C. Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J. Comp. Neurol. 267 (1988) 433-453
60. Shimada A., Yamaguchi K., and Yanagita T. Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain. Ann. N.Y. Acad. Sci. 801 (1996) 361-370
61. Shishido T., Watanabe Y., Suzuki H., Kato K., Niwa S., Hanoune J., and Matsuoka I. Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum. Neurosci. Lett. 222 (1997) 175-178
62. Shuto T., Kuroiwa M., Hamamura M., Yabuuchi K., Shimazoe T., Watanabe S., Nishi A., and Yamamoto T. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D(1) receptor agonist. Neuropharmacology 50 (2006) 991-997
63. Sizemore G.M., Co C., and Smith J.E. Ventral pallidal extracellular fluid levels of dopamine, serotonin, gamma amino butyric acid, and glutamate during cocaine self-administration in rats. Psychopharmacology (Berl.) 150 (2000) 391-398
64. Smith J.E., Koves T.R., and Co C. Brain neurotransmitter turnover rates during rat intravenous cocaine self-administration. Neuroscience 117 (2003) 461-475
65. Sprouse J.S., and Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1 (1987) 3-9
66. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res. Brain Res. Rev. 41 (2003) 203-228
67. Stewart J., and Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4 (1993) 289-312
68. Subramaniam S., Lucki I., and McGonigle P. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Res. 571 (1992) 313-322
69. Tran-Nguyen L.T., Baker D.A., Grote K.A., Solano J., and Neisewander J.L. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 146 (1999) 60-66
70. Turner M.S., Lavin A., Grace A.A., and Napier T.C. Regulation of limbic information outflow by the subthalamic nucleus: excitatory amino acid projections to the ventral pallidum. J. Neurosci. 21 (2001) 2820-2832
71. Turner M.S., Mignon L., and Napier T.C. Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion. J. Pharmacol. Exp. Ther. 301 (2002) 371-381
72. Ujike H., Akiyama K., and Otsuki S. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology (Berl.) 102 (1990) 459-464
73. van Wijngaarden I., Tulp M.T., and Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188 (1990) 301-312
74. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51 (1998) 141-153
75. White F.J., and Wang R.Y. Electrophysiological evidence for the existence of Both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J. Neurosci. 6 (1986) 274-280
76. 2-type contributions to psychomotor sensitization and reward: Implications for pharmacological treatment strategies. Clin. Neuropharmacol. 18 Suppl. 1 (1995) S74-S83
77. Yang C.R., and Mogenson G.J. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens. Brain Res. 489 (1989) 237-246
78. Zhang J., Walsh R.R., and Xu M. Probing the role of the dopamine D1 receptor in psychostimulant addiction. Ann. N.Y. Acad. Sci. 914 (2000) 13-21
79. Zilles K., Werner L., Qü M., Schleicher A., and Gross G. Quantitative autoradiography of 11 different transmitter binding sites in the basal forebrain region of the rat-evidence of heterogeneity in distribution patterns. Neuroscience 42 (1991) 473-481